AC Immune Q1 2026 Earnings EPS Slightly Beats Estimates Amid PreRevenue Stage ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady HIG Q1 2026 Earnings EPS Misses Estimates by 10 Stock Unchanged Amid Mixed Signals Primoris Services PRIM Q1 2026 Earnings EPS Misses Estimates Yet Stock Rallies FISI Q1 2026 Earnings Earnings Beat Drives EPS Above Expectations Amid Flat Revenue